Update: a briefing outlining the presentations by the speakers has been published.
Increasing the use of Next Generation Sequencing (NGS) in oncology requires further cost and technology acceleration to make the best solutions available to all types of patients. In the oncNGS project, 8 health procurers from 5 countries (BE, FR, DE, ES, IT) plan to launch a pre-commercial procurement to develop an NGS tumour-marker analysis kit applicable to all tumour types. The aim is that the kit will include automated data analysis, interpretation and reporting to support decision-making.
Update: the deadline for the public consultation has been extended until 7 May 2020.
Today, on World Cancer Day, the European Commission is launching an EU-wide public consultation on Europe’s Beating Cancer Plan. The consultation will help shape the Plan, identify key areas, and explore future action.
A summary of the exchange of views is now available.
The European Union is not at imminent risk from Rift Valley fever, but developments in neighbouring countries mean that the EU authorities and Member States should strengthen, improve and harmonise their surveillance and response capability as well as their scientific and technical expertise to be better prepared for introduction of the disease.
The event draws together more than 800 participants from over 50 countries around the world. Leading, inspiring and engaging all stakeholders to take action, ECRD is where innovative solutions in the rare disease field are born. The Conference is an unrivalled opportunity to network and exchange invaluable knowledge with all stakeholders in the rare disease community – patient representatives, policy makers, researchers, clinicians, industry representatives, payers and regulators.